Supporting Periodontal Health with a Clinically Studied Heat-Treated Postbiotic Consumers increasingly recognize that oral health is closely connected to whole-body wellness. While brushing, flossing, and mouthwash remain the foundation of daily oral care, growing awareness of the oral microbiome is expanding how consumers—and oral healthcare brands—think about supporting healthy gums and periodontal health. For oral healthcare brands, this creates an opportunity to complement traditional oral care with science-backed solutions that support the oral microbiome and the body's natural defenses. Rather than focusing solely on cleansing the teeth and mouth, emerging approaches are targeting the biological processes that help maintain a healthy oral environment. KT-11® is a proprietary, heat-treated Lactobacillus crispatus postbiotic developed to support periodontal health. Backed by human clinical research, KT-11® offers brands a differentiated approach to oral microbiome support that complements existing oral care portfolios. Consumers increasingly recognize that healthy gums and a balanced oral microbiome are important components of oral and overall wellness. As awareness of the oral microbiome grows, consumers are looking for complementary solutions that go beyond routine hygiene to provide additional periodontal and oral microbiome support. KT-11® is a clinically studied, heat-treated Lactobacillus crispatus postbiotic that supports periodontal health through the gut-immune-oral axis, offering brands an innovative way to complement established oral care regimens with science-backed oral microbiome support. This shift creates new opportunities for oral healthcare and dietary supplement brands to develop innovative oral delivery formats, including: Together, traditional oral care and microbiome-focused solutions can provide a more comprehensive approach to daily oral wellness. KT-11® supports periodontal health through the gut-immune-oral axis. Following ingestion, KT-11® interacts with the intestinal immune system, helping stimulate immune responses that extend to the oral cavity. After ingestion, KT-11® activates intestinal immune cells that increase production of immunoglobulin A (IgA), one of the body's first lines of defense at mucosal surfaces. Research suggests these IgA-producing immune cells migrate to the salivary glands, where secreted IgA helps support the mouth's natural defenses against undesirable microorganisms. KT-11® has also been shown to stimulate Porphyromonas gingivalis-specific IgG antibody responses, supporting immune recognition of one of the most well-known periodontal pathogens. Among the many bacteria found in the oral microbiome, Porphyromonas gingivalis (P. gingivalis) is widely recognized as one of the primary pathogens associated with periodontal disease. Elevated levels of P. gingivalis have been linked with gum inflammation and the destruction of tissues supporting the teeth. Human clinical research demonstrates KT-11® helps reduce the presence of P. gingivalis, supporting a healthier oral environment through immune-mediated mechanisms. KT-11® has been evaluated in a randomized, double-blind, placebo-controlled human clinical study involving 16 healthy adults who consumed 30 mg daily (approximately 12 billion heat-treated cells), as a meltable tablet for four weeks. Researchers evaluated periodontal-associated bacteria alongside multiple oral health indicators. Their key clinical findings include: In a preclinical model, KT-11® supplementation for four weeks significantly reduced the presence of both P. gingivalis and T. denticola. Researchers also observed significantly less alveolar bone resorption, suggesting KT-11® may help support the structures that anchor teeth. As a heat-treated postbiotic, KT-11® offers important formulation and handling advantages compared with live probiotics. Unlike live probiotics, KT-11® is heat-sterilized, making it significantly easier to formulate and manufacture. Benefits include: Less interaction with other formulation ingredients These attributes can simplify product development, manufacturing, transportation, and storage while providing formulators with a clinically studied postbiotic for oral health applications. KT-11® is well suited for oral delivery formats designed to provide contact within the oral cavity before swallowing. This creates opportunities for brands to incorporate postbiotic science into products that fit naturally alongside consumers' existing oral health routines. Today's consumers are increasingly interested in oral health solutions that do more than clean the surface of the teeth. Growing awareness of the oral microbiome is creating demand for complementary approaches that support healthy gums and periodontal health as part of overall wellness. KT-11® combines several important points of differentiation: a clinically studied heat-treated postbiotic, a distinctive gut-immune-oral mechanism, human research demonstrating reductions in key periodontal-associated bacteria, and the formulation advantages of a heat-treated ingredient. For brands developing innovative oral health products, KT-11® offers a science-backed way to bring oral microbiome support into established or emerging oral care portfolios. Ready to expand your oral care line with a clinically studied postbiotic? Request the KT-11® Product Brief to learn more about its clinical research, mechanism of action, formulation opportunities, and commercialization potential.
The Opportunity: Expanding the Science of Oral Health
How KT-11® Supports Oral Health
Targeting Bacteria Associated with Periodontal Health
Human Clinical Evidence
Reduced Periodontal Pathogens
Improved Oral Health Indicators
Preclinical Research Supports Periodontal Health
Why Formulators Prefer Heat-Treated Postbiotics
The Formulation Advantages of a Heat-Treated Postbiotic
Versatile Oral Delivery Opportunities
Quality You Can Trust
Why KT-11® Is Different
Bring Oral Microbiome Science to Your Product Portfolio
Lozenges
Chewable Tablets
Chewing Gum
Oral-Dissolving Tablets
Gummies
Oral Powders
